未找到相关数据
Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040
被引：0
作者：
El-Khoueiry, Anthony B.
Melero, Ignacio
Crocenzi, Todd S.
Welling, Theodore Hobart
Yau, Thomas Cheung
Yeo, Winnie
Chopra, Akhil
Grosso, Joseph
Lang, Lixin
Anderson, Jeffrey
Dela Cruz, Christine Marie
Sangro, Bruno
机构：
[1] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[2] Univ Navarra Clin, Pamplona, Spain
[3] CIBERehd, Pamplona, Spain
[4] Providence Canc Ctr, Portland, OR USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[7] Johns Hopkins Singapore Int Med Ctr, Singapore, Singapore
[8] Bristol Myers Squibb Co, Princeton, NJ USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA101
引用
收藏
页数：1
相关论文